Dr. Steven Hager
Claim this profilecCARE - Northern
Studies Squamous Cell Carcinoma
Studies Lung Cancer
2 reported clinical trials
3 drugs studied
Area of expertise
1Squamous Cell Carcinoma
Stage IV
EGFR negative
ALK negative
2Lung Cancer
Stage IV
EGFR negative
ALK negative
Affiliated Hospitals
Clinical Trials Steven Hager is currently running
Brentuximab Vedotin + Pembrolizumab
for Advanced Cancers
This trial will find out whether brentuximab vedotin and pembrolizumab work together to treat different types of cancer. There will be several different types of cancer studied in the trial. The cancer must have spread to other parts of the body (metastatic). The study will also find out what side effects occur. A side effect is anything the treatment does besides treat cancer. This is a multi-cohort study.
Recruiting1 award Phase 27 criteria
ASC61
for Cancer
This is a Phase 1, open-label, multicenter, single-arm, dose escalation study, designed to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and preliminary antitumor activity of single-agent ASC61(an orally bioavailable small-molecule inhibitor of PD-L1) in subjects with advanced solid tumors for whom no standard therapy is available.
Recruiting1 award Phase 14 criteria
More about Steven Hager
Clinical Trial Related3 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Steven Hager has experience with
- Brentuximab Vedotin
- Pembrolizumab
- ASC61
Breakdown of trials Steven Hager has run
Squamous Cell Carcinoma
Cancer
Solid Tumors
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Steven Hager specialize in?
Steven Hager focuses on Squamous Cell Carcinoma and Lung Cancer. In particular, much of their work with Squamous Cell Carcinoma has involved Stage IV patients, or patients who are EGFR negative.
Is Steven Hager currently recruiting for clinical trials?
Yes, Steven Hager is currently recruiting for 2 clinical trials in Fresno California. If you're interested in participating, you should apply.
Are there any treatments that Steven Hager has studied deeply?
Yes, Steven Hager has studied treatments such as Brentuximab Vedotin, Pembrolizumab, ASC61.
What is the best way to schedule an appointment with Steven Hager?
Apply for one of the trials that Steven Hager is conducting.
What is the office address of Steven Hager?
The office of Steven Hager is located at: cCARE - Northern, Fresno, California 93720 United States. This is the address for their practice at the cCARE - Northern.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.